Cite
HARVARD Citation
Esnault, C. et al. (2022). Adcitmer®, a new CD56‐targeting monomethyl auristatin E‐conjugated antibody, is a potential therapeutic approach in Merkel cell carcinoma. British journal of dermatology. pp. 295-306. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Esnault, C. et al. (2022). Adcitmer®, a new CD56‐targeting monomethyl auristatin E‐conjugated antibody, is a potential therapeutic approach in Merkel cell carcinoma. British journal of dermatology. pp. 295-306. [Online].